| Symbol |
SIRT7 |
| Full Name |
Sirtuin 7 (Nuclear NAD-dependent deacetylase) |
| Chromosome |
17q25.3 |
| NCBI Gene |
23433 |
| Ensembl |
ENSG00000117595 |
| OMIM |
613213 |
| UniProt |
Q9H0U6 |
| Protein Class |
NAD-dependent class III deacetylase |
| Expression |
High in brain ([cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), substantia nigra), heart, liver |
| Diseases |
Alzheimer's Disease, Parkinson's Disease, Cancer, Metabolic Disorders |
SIRT7 (Sirtuin 7) is a NAD+-dependent nuclear class III deacetylase predominantly localized to nucleoli where it regulates ribosomal RNA transcription and ribosome biogenesis. It is the least characterized mammalian sirtuin but has emerging roles in stress response, metabolism, and more recently, neurodegeneration. SIRT7 is involved in protein homeostasis and cellular stress adaptation, with growing evidence supporting its neuroprotective functions in Alzheimer's disease, Parkinson's disease, and aging-related neurodegeneration.
SIRT7 is one of seven mammalian sirtuins (SIRT1-7), a family of NAD+-dependent deacetylases and ADP-ribosyltransferases evolutionarily conserved from yeast to humans. While SIRT1 and SIRT2 have been extensively studied in neurodegeneration, SIRT7 represents an emerging area of research with unique substrate specificity and cellular localization. The enzyme is primarily nucleolar, where it associates with RNA polymerase I to regulate ribosomal RNA synthesis, linking cellular metabolic status to protein synthesis capacity.
¶ Structure and Molecular Biology
SIRT7 is a 400-amino acid protein with the characteristic sirtuin core domain structure:
| Domain |
Residues |
Function |
| N-terminal region |
1-80 |
Substrate binding, regulatory motifs |
| Core deacetylase domain |
80-350 |
NAD+ binding, catalytic activity |
| C-terminal region |
350-400 |
Protein interactions, localization |
SIRT7 possesses unique enzymatic properties:
- NAD+ dependency: Uses NAD+ as cofactor for deacetylation
- Deacetylase activity: Removes acetyl groups from lysine residues
- ADP-ribosyltransferase activity: Catalyzes ADP-ribosylation reactions
- Substrate specificity: Distinct from other sirtuins
The SIRT7 protein contains:
- Rossmann-fold core: NAD+ binding and catalytic site
- Catalytic loop: Contains the conserved H-Y-I motif
- Nucleolar targeting signal: Directs to nucleolar compartment
- Flexible C-terminus: Mediates protein-protein interactions
SIRT7's primary function is regulation of ribosome biogenesis :
- RNA Pol I association: SIRT7 associates with RNA polymerase I
- Transcription elongation: Facilitates transcript elongation
- rRNA processing: Coordinates with processing factors
- Ribosome assembly: Links transcription to assembly
The enzyme deacetylates transcription factors that regulate rRNA genes, enhancing transcription efficiency and maintaining nucleolar function.
SIRT7 modulates chromatin states:
- Histone deacetylation: Targets H3K18ac, H3K36ac
- Transcriptional repression: Regulates gene expression
- Stress response genes: Modulates stress-activated programs
SIRT7 connects metabolism to cellular function:
- NAD+ sensing: Links cellular energy status to function
- Mitochondrial regulation: Affects mitochondrial biogenesis
- Lipid metabolism: Regulates lipogenic programs
- Stress adaptation: Coordinates stress responses
SIRT7 is expressed throughout the brain:
- Cortex: Pyramidal neurons, interneurons
- Hippocampus: CA neurons, dentate gyrus granule cells
- Substantia nigra: Dopaminergic neurons
- Cerebellum: Purkinje cells, granule cells
In neurons, SIRT7 participates in:
- Protein homeostasis: Maintains proteostasis via ribosome regulation
- Stress response: Coordinates cellular stress responses
- Mitochondrial function: Regulates neuronal metabolism
- Synaptic plasticity: Affects synaptic function
- Nucleolus: Primary site of ribosome biogenesis
- Nucleus: Chromatin regulation
- Cytoplasm: Ribosomal protein synthesis
- Mitochondria: Metabolic regulation
SIRT7 has emerging protective roles in AD :
- Altered SIRT7 expression in AD brain
- Reduced nucleolar function in AD neurons
- Links to ribosomal dysfunction
- Correlations with tau pathology
- Ribosome biogenesis maintenance
- Proteostasis support
- Stress granule regulation
- Mitochondrial function
- SIRT7 activators may protect neurons
- Enhancement of ribosome function
- Restoration of protein synthesis
- Combination with other sirtuins
SIRT7 is implicated in PD through dopaminergic neuron vulnerability :
- Reduced SIRT7 in PD substantia nigra
- Impaired ribosome function in PD neurons
- Links to alpha-synuclein pathology
- Mitochondrial dysfunction connections
- Mitochondrial quality control
- Ribosomal protein homeostasis
- Stress response coordination
- Dopaminergic neuron survival
SIRT7 deficiency contributes to age-related neurodegeneration :
- Progressive motor dysfunction
- Cognitive decline
- Neuronal loss
- Premature aging phenotype
While SIRT7 has complex roles in cancer:
- Often overexpressed in tumors
- Links to ribosome biogenesis
- Metabolic reprogramming
- May be therapeutic target
¶ SIRT7 and Neuroinflammation
SIRT7 modulates neuroinflammation :
- Pro-inflammatory genes: Represses inflammatory transcription
- Microglial activation: Affects microglial function
- Cytokine production: Modulates inflammatory mediators
- Aging effects: Age-related inflammation increase
- SIRT7 enhancement may reduce neuroinflammation
- Protects neurons from inflammatory damage
- Potential for inflammatory disease treatment
SIRT7 regulates ribosomal proteins :
- Ribosome assembly: Ensures proper assembly
- Protein synthesis: Balances synthesis and degradation
- Stress granules: Coordinates with stress response
SIRT7 integrates with cellular quality control:
SIRT7 affects neuronal metabolism :
- Mitochondrial biogenesis: Promotes mitochondrial formation
- Energy production: Maintains ATP levels
- Calcium handling: Modulates calcium homeostasis
- Oxidative stress: Protects against ROS damage
Mitochondrial dysfunction is central to:
- Alzheimer's disease progression
- Parkinson's disease pathogenesis
- Aging-related decline
flowchart TD
subgraph Normal_Function
A["SIRT7 Gene<br/>(17q25.3)"]:::blue --> B["SIRT7 Protein<br/>(Nucleolar)"]:::blue
B --> C["rRNA<br/>Transcription"]:::green
B --> D["Ribosome<br/>Biogenesis"]:::green
B --> E["Mitochondrial<br/>Function"]:::green
end
subgraph Stress_Response
C --> F["Protein<br/>Synthesis"]:::orange
D --> F
E --> G["Energy<br/>Metabolism"]:::orange
F --> H["Proteostasis"]:::green
end
subgraph Neurodegeneration
I["Cellular Stress<br/>(Oxidative, Proteotoxic)"]:::red --> J["Impaired<br/>Ribosome Function"]:::red
J --> K["Protein<br/>Homeostasis Failure"]:::red
K --> L["Mitochondrial<br/>Dysfunction"]:::red
L --> M["Neuronal<br/>Death"]:::red
end
subgraph Disease_Linkages
M --> N["Alzheimer's"]:::red
M --> O["Parkinson's"]:::red
end
subgraph Therapeutic_Targets
B --> P["SIRT7<br/>Activators"]:::blue
P --> Q["Restored<br/>Ribosome Function"]:::green
Q --> R["Neuronal<br/>Protection"]:::green
end
classDef blue fill:#e1f5fe,stroke:#333
classDef green fill:#c8e6c9,stroke:#333
classDef orange fill:#fff3e0,stroke:#333
classDef red fill:#ffcdd2,stroke:#333
SIRT7 represents a promising target:
- SIRT7 activators: Small molecules to enhance activity
- NAD+ precursors: Increase available NAD+
- Gene therapy: Deliver SIRT7 to neurons
- Modulators: Target specific substrates
- Delivery across blood-brain barrier
- Specificity vs. other sirtuins
- Balancing activity levels
- Timing of intervention
| Sirtuin |
Location |
Main Function |
Neuroprotective |
| SIRT1 |
Nucleus/Cytoplasm |
Deacetylase, stress response |
Yes |
| SIRT2 |
Cytoplasm |
Tubulin deacetylation |
Yes |
| SIRT3 |
Mitochondria |
Metabolic regulation |
Yes |
| SIRT4 |
Mitochondria |
ADP-ribosyltransferase |
Emerging |
| SIRT5 |
Mitochondria |
Demalonylation |
Emerging |
| SIRT6 |
Nucleus |
Chromatin regulation |
Yes |
| SIRT7 |
Nucleolus |
Ribosome biogenesis |
Emerging |
¶ Genetic Variants and Polymorphisms
- Expression variants affecting SIRT7 levels
- Coding variants altering function
- Regulatory variants in disease risk
- Variable expression across populations
- Association with longevity genes
- Interaction with other sirtuins
¶ Mouse Models and Research Insights
SIRT7 knockout mice show:
- Premature aging
- Degenerative phenotypes
- Ribosome biogenesis defects
- Metabolic abnormalities
Neuron-specific models reveal:
- Neurodegeneration phenotypes
- Motor dysfunction
- Cognitive deficits
- Increased vulnerability
- SIRT7 activator efficacy
- NAD+ supplementation effects
- Gene therapy approaches
SIRT7 interacts with:
- RNA Pol I components: Transcription machinery
- Histone deacetylases: Chromatin regulation
- Ribosomal proteins: Assembly factors
- Transcription factors: Specific targets
SIRT7 connects to:
- mTOR signaling: Growth regulation
- AMPK pathway: Energy sensing
- P53 pathway: Stress response
- Sirtuin network: Cross-talk
- What are the neuronal-specific substrates?
- How does SIRT7 decline with age?
- Can SIRT7 activation slow neurodegeneration?
- Substrate identification
- Structure-based drug design
- Gene therapy vectors
- Biomarker development
SIRT7 measurement offers potential:
- Protein levels as biomarker
- Activity assays
- Genetic testing
- SIRT7 expression guides therapy
- Genetic variants inform risk
- Disease subtype classification